Tenaya Therapeutics, Inc. · NASDAQ:TNYA
Ali Faraz sold 22,232 Tenaya Therapeutics, Inc. shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 17, 2026
On Aug 17, 2026, Ali Faraz (Director, Chief Executive Officer) sold 22,232 Tenaya Therapeutics, Inc. shares at US$0.71 for US$15,785, leaving 417,782 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 22,232 shares
- Price
- US$0.71
- Value
- US$15,785
- Holding after
- 417,782 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Sale | 5,837 | US$0.71 | 434,177 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 3,969 | US$0.71 | 430,208 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 5,020 | US$0.71 | 425,188 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 7,406 | US$0.71 | 417,782 | Direct |
Source
Related
- Tenaya Therapeutics, Inc.
- Ali Faraz
- Tenaya Therapeutics, Inc. shareholders
- Form 4 · Ali Faraz · Sep 11, 2026
- Form 4 · Ali Faraz · May 19, 2026
- Form 4 · Tingley Whittemore · Sep 11, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Form 4 · Tingley Whittemore · Aug 17, 2026
- Form 4 · Tingley Whittemore · May 19, 2026
- Form 4 · Higa Tomohiro · May 19, 2026